Laboratoire Acides Nucléiques et BioPhotonique (ANBioΦ) Université Pierre & Marie Curie, Tour 32-33, 4èmeétage, 4 place Jussieu, F-75252, Paris Cedex05, France.
Photochem Photobiol Sci. 2012 Apr;11(4):703-14. doi: 10.1039/c2pp05354c. Epub 2012 Feb 6.
Antioxidants may affect the outcome of photodynamic therapy (PDT) through the inactivation of reactive oxygen species. Their direct interaction with photosensitizers excited at the triplet state is also worthy of interest. This process is investigated by laser flash photolysis of m-THPC (meso-tetra(3-hydroxyphenyl)chlorin, Foscan) hydroalcoholic solutions added with Trolox (TrOH), a standard antioxidant or Propofol (PfOH, Diprivan(®)), a common anesthetic agent also characterized for its antioxidant properties. Transient UV-visible absorption spectra, kinetics at selected wavelengths and final spectra after extensive laser irradiation show that both compounds react with the m-THPC triplet state, (3)m-THPC, to ultimately restore the photosensitizer in its ground state. For PfOH, this process mainly appears as a single step obeying pseudo-first order kinetics. The bimolecular rate constant for the quenching of (3)m-THPC by PfOH is around 2 × 10(6) M(-1) s(-1), a value increased to some extent by the water content of the solution. A bimolecular reaction between (3)m-THPC and TrOH is observed with a rate constant of similar magnitude and dependence upon water. However, the reaction leads, at least partly, to intermediate species assigned to the TrO˙ radical and the m-THPC anion radical. Within a few ms, these species back react to yield m-THPC in its ground state. A general mechanism involving an intermediate activated complex with some charge transfer character is proposed. Depending on the redox potentials for the oxidation of the antioxidant, this complex evolves predominantly either toward the formation of radicals (TrOH) or back to the photosensitizer ground state (PfOH). Notably, the kinetics data suggest that Propofol may quench (3)m-THPC at concentrations relevant of clinical situation in PDT involving anesthesia.
抗氧化剂可能通过使活性氧失活来影响光动力疗法(PDT)的结果。它们与三重态激发的光敏剂的直接相互作用也值得关注。通过添加 Trolox(TrOH)或丙泊酚(PfOH,Diprivan(®))的 m-THPC(间-四(3-羟基苯基)氯,Foscan)水醇溶液的激光闪光光解来研究该过程,这两种化合物均与 m-THPC 三重态(3)m-THPC 反应,最终将光敏剂恢复到基态。对于 PfOH,该过程主要表现为遵循准一级动力学的单一步骤。PfOH 猝灭(3)m-THPC 的双分子速率常数约为 2×10(6)M(-1)s(-1),该值在一定程度上受溶液含水量的影响。观察到(3)m-THPC 与 TrOH 之间的双分子反应,其速率常数具有相似的大小,并取决于水。但是,该反应至少部分导致分配给 TrO˙自由基和 m-THPC 阴离子自由基的中间物种。在几毫秒内,这些物质会反向反应以产生基态的 m-THPC。提出了一种涉及具有一定电荷转移特征的中间活化配合物的通用机制。根据抗氧化剂氧化的氧化还原电位,该配合物主要向自由基(TrOH)的形成或向光敏剂基态(PfOH)的形成演化。值得注意的是,动力学数据表明,在涉及麻醉的 PDT 中,丙泊酚可能会在与临床情况相关的浓度下猝灭(3)m-THPC。